PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL)
Clinical trials for PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL) trials appear
Sign up with your email to follow new studies for PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for lymphoma patients Who've run out of options
Disease control CompletedThis study tested whether giving the immunotherapy drug pembrolizumab every six weeks could help control two types of lymphoma that had returned or stopped responding to previous treatments. It involved 66 adults with relapsed Hodgkin's lymphoma or primary mediastinal large B-cel…
Matched conditions: PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL)
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Doctors look back: how well did lymphoma treatments really work?
Knowledge-focused CompletedThis study looked back at the medical records of 633 adults with a rare chest lymphoma (PMBCL) treated between 2007 and 2019. Researchers analyzed which standard chemotherapy treatments patients received and how well they worked in real-world hospital settings, outside of strict …
Matched conditions: PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL)
Sponsor: Fondazione Italiana Linfomi - ETS • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC